Aurobindo Ph Sept '08 qtr PAT seen at Rs 286.8 Cr: Religare
Religare Hichens Harrison Research has come out with its earning estimates on Pharma sector for the quarter ended September 2008. According to the research firm, Aurobindo Pharma September quarter sales is expected to go up 24.2% at Rs 13,640 million (Rs 1364 crore) on YoY basis.